EQS-News: Formycon AG / Key word (s): Regulatory Approval Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® ...
IST, the barometer index, the S&P BSE Sensex, advanced 183.55 points or 0.25% to 74,645.46. The Nifty 50 index added 19.75 points or 0.09% to 22,573.10.
Biocon share price rose by 2.5% after its arm launched Yesintek, a biosimilar for autoimmune disorders in the US. Approved ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果